Get started
Author

Henning Friis Andersen

Observed names: Andersen, H.F., Andersen, Henning F., H. Andersen, H. F. Andersen, H.F. Andersen, Henning F Andersen, Henning F. Andersen
OpenAlex ID: A5111800487
Safety of Recombinant Activated Factor VII in Randomized Clinical Trials
2010 · Marcel Levi, Jerrold H. Levy, et al. · New England Journal of Medicine · 679
PDF
Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis
2006 · Sidney H. Kennedy, Henning F. Andersen, et al. · Journal of Psychiatry and Neuroscience · 218
What Is the Threshold for Symptomatic Response and Remission for Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, and Generalized Anxiety Disorder?
2006 · Borwin Bandelow, David S. Baldwin, et al. · The Journal of Clinical Psychiatry · 208
Escitalopram in the treatment of major depressive disorder: A meta-analysis
2008 · Sidney H. Kennedy, Henning F. Andersen, et al. · Current Medical Research and Opinion · 143
Escitalopram in the Treatment of Depressed Elderly Patients
2005 · Siegfried Kasper, Hans de Swart, et al. · American Journal of Geriatric Psychiatry · 126
Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder
2004 · Ulla Lepola, Alan Wade, et al. · International Clinical Psychopharmacology · 92
Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression
2002 · P. Bech, P. Tanghøj, et al. · Psychopharmacology · 90
Analysis of the Effect of Memantine in Reducing the Worsening of Clinical Symptoms in Patients with Moderate to Severe Alzheimer’s Disease
2007 · David Wilkinson, Henning Friis Andersen · Dementia and Geriatric Cognitive Disorders · 87
A randomized, double-blind, 24‐week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder
2005 · Lucien Colonna, Henning Friis Andersen, et al. · Current Medical Research and Opinion · 82
Escitalopram dose–response revisited: an alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depression
2004 · Per Bech, Per Tanghøj, et al. · The International Journal of Neuropsychopharmacology · 74
PDF
Escitalopram versus venlafaxine XR in the treatment of depression
2006 · Stuart A. Montgomery, Henning F. Andersen · International Clinical Psychopharmacology · 60
Baseline severity of depression predicts antidepressant drug response relative to escitalopram
2009 · Clinton D Kilts, Alan G Wade, et al. · Expert Opinion on Pharmacotherapy · 58
Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder
2008 · Koen Demyttenaere, Henning Friis Andersen, et al. · International Clinical Psychopharmacology · 55
The onset of effect for escitalopram and its relevance for the clinical management of depression
2006 · Alan Wade, Henning Friis Andersen · Current Medical Research and Opinion · 47
Repletion of factor XIII following cardiopulmonary bypass using a recombinant A-subunit homodimer: A preliminary report
2009 · Ravi Gill, Nancy A. Nussmeier, et al. · Thrombosis and Haemostasis · 46
Escitalopram in the treatment of anxiety symptoms associated with depression
2006 · Borwin Bandelow, Henning F. Andersen, et al. · Depression and Anxiety · 40
Escitalopram for the Treatment of GAD: Efficacy Across Different Subgroups and Outcomes
2005 · Dan Stein, Henning Friis Andersen, et al. · Annals of Clinical Psychiatry · 38
Escitalopram Versus SNRI Antidepressants in the Acute Treatment of Major Depressive Disorder: Integrative Analysis of Four Double-Blind, Randomized Clinical Trials
2009 · Susan G. Kornstein, Dayong Li, et al. · CNS Spectrums · 34
The effect of escitalopram on sleep problems in depressed patients
2005 · M. Lader, H. F. Andersen, et al. · Human Psychopharmacology Clinical and Experimental · 34
Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials
2008 · Raymond W. Lam, Henning F. Andersen, et al. · International Clinical Psychopharmacology · 29
Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD)
2008 · A.G. Wade, T.E. Schlaepfer, et al. · Journal of Psychiatric Research · 23
Anxiety Symptom Severity and Functional Recovery Or Relapse
2009 · Dan J. Stein, Borwin Bandelow, et al. · Annals of Clinical Psychiatry · 15
Qualitative changes in symptomatology as an effect of treatment with escitalopram in generalized anxiety disorder and major depressive disorder
2007 · Yves Lecrubier, Ornah T. Dolberg, et al. · European Archives of Psychiatry and Clinical Neuroscience · 8
Safety and Preliminary Efficacy of Recombinant Activated FVII Analog (NN1731) In the Treatment of Joint Bleeds In Congenital Hemophilia Patients with Inhibitors
2010 · Erich de Paula, Kaan Kavakli, et al. · Blood · 3
Comparison of the standard scales and CGI scores in major depressive disorder, panic disorder, social anxiety disorder and generalized anxiety disorder
2006 · Borwin Bandelow, David S. Baldwin, et al. · ePrints Soton (University of Southampton) · 1
Works count: 36
Citation count: 2,290
H-index: 21
I10-index: 22
Year
Topic
Type